News in Numbers

The UK NHS reported almost 3 million people (2,980,258) were seen for urgent cancer checks from Nov 2022 to Oct 2023 – the highest year on record. The new analysis showed there has been a 133% increase in the number of people getting checked for cancer.

Boston Scientific is growing its urology portfolio with a $3.7 billion deal to acquire Axonics, the maker of neurostimulation therapies for urinary and fecal incontinence.

Thermo Fisher Scientific is closing its Petaluma, CA, facility in July 2024 and will not renew its lease. The company said it is laying off 74 staffers effective February from the same site.

Veracyte has inked a $95 million deal to buy fellow cancer testing company C2i Genomics. The deal was announced at the J.P. Morgan Healthcare Conference in San Francisco.

Health tech startups raised $10.7 billion across 492 deals in 2023, the lowest amount of capital in four years, according to digital health research and venture firm Rock Health’s 2023 end-of-year report.